Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

XTNT - Xtant Medical Holdings, Inc.

Close
0.562
0   0%

Share volume: 0
Last Updated: Fri 20 Dec 2024 09:01:20 PM CET

PREVIOUS CLOSE
CHG
CHG%
$0.56
-0.20
0.53%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-0.69%
1 Month
-8.88%
3 Months
-51.35%
6 Months
-42.86%
1 Year
-70.49%
2 Year
-46.75%
Key data
Stock price
$0.56
P/E Ratio 
0.00
DAY RANGE
$0.37 - $0.56
EPS 
$0.00
52 WEEK RANGE
$0.37 - $1.31
52 WEEK CHANGE
-$70.49
MARKET CAP 
96.433 M
YIELD 
N/A
SHARES OUTSTANDING 
130.314 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.15
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$314,002
AVERAGE 30 VOLUME 
$224,663
Company detail
CEO: Sean E. Browne
Region: US
Website: xtantmedical.com
Employees: 120
IPO year: -
Issue type: Common Stock
Market: NYSE American
Industry:
Sector:

Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment. The company also provides 3Demin, a family of allografts that maximizes osteoconductivity and osteoinductive potential of human bone.

Recent news